North America

Sun
17
Feb

State restrictions on cannabis packaging worry producers

Since starting Fairwinds, a Vancouver-based cannabis company, in 2014, James and Wendy Hull said they’ve heard from customers who’ve praised their products for helping them with pain, anxiety and other ailments – even cancer.

Because of state regulations, the packaging for the company’s infused tinctures, topicals, capsules and other products contains no information claiming any therapeutic effects. The couple are also cautious in how they describe their products. The products made in Fairwinds’ east Vancouver headquarters have names such as “Deep Sleep,” “Digestify” and “AM Relief” that hint at the possible effects of each product.

“That’s the only place we’re allowed to explain the intent of the product,” Wendy Hull said.

Sun
17
Feb

Cannabis seeds – understanding the basics

Growing Cannabis from seeds for people who are interested in doing this at home is a new thing for many people. We recognize that. It’s also worth pointing out that the law is changing rapidly around the topic of Cannabis, with many countries now moving to legalize some, if not all, aspects of growing or possessing it. Ensure it’s legal for you in your country before proceeding. That’s solely your responsibility and yours alone. 

Sun
17
Feb

Opinion: Here’s why the craft cannabis industry can thrive in the face of big marijuana

In 2012, Washington and Colorado became the first states to legalize recreational marijuana. Since then, more states have followed. To date, 33 states have legalized the recreational or medicinal use of marijuana. Canada legalized recreational use nation-wide in October 2018.

Sun
17
Feb

The link between cannabis use and the common cold

The potential medical applications of cannabis seem boundless—there are an array of terminal and debilitating illnesses that may, in time, be successfully remedied with the plant. However, for those cannabis users that aren’t treating life threatening diseases and disorders, how does medical marijuana fit into a normal health regiment? More specifically, what sort of role, if any, does cannabis play when it comes to dealing with the common cold and flu?

As the fall season slowly begins fading into the winter months, an influx in cool weather is a sure harbinger for cold and flu season. Therefore, the marijuana-using population should be conscious of how their consumption should be regimented during this time.

Sun
17
Feb

Popular book on marijuana's apparent dangers is pure alarmism, experts say

Agroup of 75 scholars and medical professionals have criticised a controversial new book about the purported dangers of marijuana, calling it an example of “alarmism” designed to stir up public fear “based on a deeply inaccurate misreading of science”.

Sun
17
Feb

Is the cannabis bubble finally about to burst?

The sentiment that cannabis stocks have reached “bubble-territory” are “wildly overvalued,” or “due for a major correction” would be at this point anything but a novel concept.

As a matter of fact, many skeptics have been saying exactly these things for what seems like forever.

Circumstances in the cannabis industry have begun to catch up to themselves, which could lead to a sharp downturn in valuations for legal cannabis producers.

Sun
17
Feb

Surprise! The biggest marijuana ETF just made a massive move

Investors are more excited about the marijuana market than ever, and stocks in the cannabis space have seen dramatic gains to start the year. As a result, the biggest marijuana ETF in the business, the ETFMG Alternative Harvest (NYSEMKT:MJ), has rewarded its investors with nice returns so far in 2019.

Fri
15
Feb

Canopy Growth revenue soars, but so does its loss from operations

Canopy Growth Corp. says it generated $97.7 million of revenue in the three months ended Dec. 31, including its first sales of non-medical cannabis products, up from $21.7 million in the previous year’s fiscal third quarter.

The Ontario-based company — one of Canada’s largest cannabis producers — recorded a loss from operations for the quarter, but turned a net profit due to gains on the fair value of its assets and liabilities.

Loss from operations was $157.2 million, compared with a loss of $26 million a year earlier.

Net income attributable to shareholders, including net gains on the fair value of its assets, was $67.6 million or 22 cents per basic share, up from $1.6 million or one cent per basic share a year earlier.

Fri
15
Feb

Will the legalization of recreational marijuana be the death knell for medical cannabis?

Is the medical marijuana market dying?

Some people have argued that when recreational cannabis is legalized it will effectively push out the medical market, writes Calvin Hughes. Patients will forgo the hassle of getting a registered medical marijuana card and will instead frequent the local shops that require nothing more than a standard piece of government ID.

Fri
15
Feb

Will Aurora Cannabis continue bleeding money in 2019?

Aurora Cannabis (NYSE:ACB) lost a frightening amount of money during the last three months of 2018 and investors are justifiably concerned about more losses ahead. Despite posting heavy losses, management expects a sales explosion before the end of 2019 that could allow this giant Canadian cannabis producer to begin posting a profit by the end of the year.

Should investors brace for further losses ahead, or will Aurora Cannabis find a way to make ends meet before the end of 2019? Here's what you need to know to decide for yourself.

Pages

Subscribe to RSS - North America